scorecardresearch
Add as a preferred source on Google
Thursday, April 30, 2026
TopicAstraZeneca

Topic: AstraZeneca

Experimental drug shows promise in treatment of hard-to-control high blood pressure

AstraZeneca’s experimental drug baxdrostat cut systolic BP by nearly 10 mmHg in a late-stage trial, offering hope to patients at a high risk of heart attacks, among others.

Months after import duty waiver, GST slashed on same 3 anti-cancer drugs. Why this is little relief

Centre moves to reduce costs of trastuzumab deruxtecan, osimertinib & durvalumab, all 3 by British-Swedish pharma giant AstraZeneca. Doctors seek exemptions for more such drugs. 

How safe is AstraZeneca Covid vaccine & why there is no need to panic — some key questions answered

51 cases have been lodged in a UK court against biopharma company over claims that its Covid vaccine caused death and injury in several cases.

Modi photo missing from Covid vaccine certificates due to model code, say health ministry officials

Prime Minister Narendra Modi’s photo was also removed from Covid-19 vaccination certificates issued in 5 poll-bound states in 2022 at EC's directions.

Don’t let anti-vaxxers weaponise AstraZeneca furore. Vaccines are safe—and we are the proof

Vaccines have eliminated two diseases—smallpox in humans and rinderpest in cattle. If they were killing one in 50,000 people, we wouldn’t be rolling them out across the globe for decades.

AstraZeneca vaccine safe, effective in kids, finds Lancet study. WHO still says for adults only

The vaccine, marketed as Covishield in India, induced antibody concentrations in children similar to those associated with high efficacy in adults, says study by UK researchers.

Covishield shows increased antibody response to Omicron after 3rd dose: AstraZeneca

Preliminary data released by AstraZeneca shows Vaxzevaria vaccine, administered in India as Covishield, increased immune response to Beta, Delta, Alpha, Gamma variants after third dose.

AstraZeneca’s antibody cocktail gets US nod for Covid prevention in those with low immunity

According to company Evusheld 'neutralises all previous SARs-CoV-2 variants to date'. AstraZeneca now intends to apply for approval in India.

Booster dose of 6 Covid vaccines is safe, increases immunity, shows study in Lancet

The study looked at safety, immune response and side-effects of seven vaccines — Oxford-AstraZeneca, Pfizer-BioNTech, Novavax, Janssen, Moderna, Valneva and Curevac.

AstraZeneca vaccine has no adverse impact on pregnancy or fertility, study in Lancet says

In the study spanning UK, Brazil and South Africa, the rate of miscarriage was roughly the same between vaccine and placebo groups, & no still births or neonatal deaths were recorded.

On Camera

New promo video by PLA Navy is a teaser of China’s deep blue capabilities

Rather than functioning as conventional propaganda, the video operates as a device for interpretation, subtly shaping expectations about future developments in China’s naval trajectory.

Adani’s giant copper plant hits technical setbacks in first year

The 500,000 tonne-per-year plant produced just 94,000 tonnes of refined copper from April 2025 to February this year.

Indian drone tech company ideaForge signs MoU with Japanese firm to develop next-gen AI powered drones

By pairing Indian drone engineering with Japanese semiconductor expertise, the two firms aim to develop more advanced autonomous systems tailored to both defence & commercial use.

Trump, Netanyahu’s Iran gamble: The regime change rebound

American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.